Click on image to view larger version.

Figure 1 Percent platelet aggregation (± SEM) to ADP (20 µmol/liter) and TRAP (5 µmol/liter) in patients on placebo (n = 24–31) (diamond); orbofiban 30 mg bid (n = 17–29) (solid square); 40 mg bid (n = 21–29) (diamond); 50 mg qd (n = 16–29) (open square); and 50 mg bid (n = 18–31) (open circle).